-
1
-
-
79960085327
-
Duchenne cardiomyopathy gene therapy
-
New York: Springer Science + Business Media, LLC, Duan D
-
Shin J-H, Bostick B, Yue Y, Duan D. Duchenne cardiomyopathy gene therapy. Muscle gene therapy 2010, 141-162. New York: Springer Science + Business Media, LLC, Duan D.
-
(2010)
Muscle gene therapy
, pp. 141-162
-
-
Shin, J.-.H.1
Bostick, B.2
Yue, Y.3
Duan, D.4
-
2
-
-
0025822356
-
Total ion content of skeletal and cardiac muscle in the mdx mouse dystrophy: Ca2+ is elevated at all ages
-
10.1016/0022-510X(91)90168-7, 1880541
-
Dunn JF, Radda GK. Total ion content of skeletal and cardiac muscle in the mdx mouse dystrophy: Ca2+ is elevated at all ages. J Neurol Sci 1991, 103:226-231. 10.1016/0022-510X(91)90168-7, 1880541.
-
(1991)
J Neurol Sci
, vol.103
, pp. 226-231
-
-
Dunn, J.F.1
Radda, G.K.2
-
3
-
-
0029156089
-
Properties of cardiac cells from dystrophic mouse
-
10.1016/S0022-2828(95)91019-0, 8523438
-
Alloatti G, Gallo MP, Penna C, Levi RC. Properties of cardiac cells from dystrophic mouse. J Mol Cell Cardiol 1995, 27:1775-1779. 10.1016/S0022-2828(95)91019-0, 8523438.
-
(1995)
J Mol Cell Cardiol
, vol.27
, pp. 1775-1779
-
-
Alloatti, G.1
Gallo, M.P.2
Penna, C.3
Levi, R.C.4
-
4
-
-
33846958084
-
Intracellular calcium handling in ventricular myocytes from mdx mice
-
Williams IA, Allen DG. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol 2007, 292:H846-855.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
-
-
Williams, I.A.1
Allen, D.G.2
-
5
-
-
76549098001
-
Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy
-
10.1073/pnas.0908540107, 2824377, 20080623
-
Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2010, 107:1559-1564. 10.1073/pnas.0908540107, 2824377, 20080623.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 1559-1564
-
-
Fauconnier, J.1
Thireau, J.2
Reiken, S.3
Cassan, C.4
Richard, S.5
Matecki, S.6
Marks, A.R.7
Lacampagne, A.8
-
6
-
-
77955592742
-
Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy
-
10.1073/pnas.1004509107, 2919918, 20615971
-
Sarma S, Li N, van Oort RJ, Reynolds C, Skapura DG, Wehrens XH. Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. Proc Natl Acad Sci USA 2010, 107:13165-13170. 10.1073/pnas.1004509107, 2919918, 20615971.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 13165-13170
-
-
Sarma, S.1
Li, N.2
van Oort, R.J.3
Reynolds, C.4
Skapura, D.G.5
Wehrens, X.H.6
-
7
-
-
0037216819
-
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation
-
10.1016/S0008-6363(02)00694-6, 12504810
-
Frank KF, Bolck B, Erdmann E, Schwinger RH. Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 2003, 57:20-27. 10.1016/S0008-6363(02)00694-6, 12504810.
-
(2003)
Cardiovasc Res
, vol.57
, pp. 20-27
-
-
Frank, K.F.1
Bolck, B.2
Erdmann, E.3
Schwinger, R.H.4
-
8
-
-
50649097202
-
The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases
-
10.1038/ncpcardio1301, 18665137
-
Kawase Y, Hajjar RJ. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases. Nat Clin Pract Cardiovasc Med 2008, 5:554-565. 10.1038/ncpcardio1301, 18665137.
-
(2008)
Nat Clin Pract Cardiovasc Med
, vol.5
, pp. 554-565
-
-
Kawase, Y.1
Hajjar, R.J.2
-
9
-
-
72449171512
-
Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure
-
10.1517/14712590903321462, 3001226, 20078230
-
Lipskaia L, Chemaly ER, Hadri L, Lompre AM, Hajjar RJ. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure. Expert Opin Biol Ther 2010, 10:29-41. 10.1517/14712590903321462, 3001226, 20078230.
-
(2010)
Expert Opin Biol Ther
, vol.10
, pp. 29-41
-
-
Lipskaia, L.1
Chemaly, E.R.2
Hadri, L.3
Lompre, A.M.4
Hajjar, R.J.5
-
10
-
-
0141514416
-
Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts
-
10.1016/j.bbrc.2003.09.005, 14511675
-
Rohman MS, Emoto N, Takeshima Y, Yokoyama M, Matsuo M. Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts. Biochem Biophys Res Commun 2003, 310:228-235. 10.1016/j.bbrc.2003.09.005, 14511675.
-
(2003)
Biochem Biophys Res Commun
, vol.310
, pp. 228-235
-
-
Rohman, M.S.1
Emoto, N.2
Takeshima, Y.3
Yokoyama, M.4
Matsuo, M.5
-
11
-
-
70449119011
-
Systemic trans-splicing AAV delivery efficiently transduces the heart of adult mdx mouse, a model for Duchenne muscular dystrophy
-
10.1089/hum.2009.058, 2829465, 19627234
-
Ghosh A, Yue Y, Shin J-H, Duan D. Systemic trans-splicing AAV delivery efficiently transduces the heart of adult mdx mouse, a model for Duchenne muscular dystrophy. Hum Gene Ther 2009, 20:1319-1328. 10.1089/hum.2009.058, 2829465, 19627234.
-
(2009)
Hum Gene Ther
, vol.20
, pp. 1319-1328
-
-
Ghosh, A.1
Yue, Y.2
Shin, J.-.H.3
Duan, D.4
-
12
-
-
50649083054
-
Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice
-
10.1089/hum.2008.058, 2888653,2888653, 18666839
-
Bostick B, Yue Y, Lai Y, Long C, Li D, Duan D. Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther 2008, 19:851-856. 10.1089/hum.2008.058, 2888653,2888653, 18666839.
-
(2008)
Hum Gene Ther
, vol.19
, pp. 851-856
-
-
Bostick, B.1
Yue, Y.2
Lai, Y.3
Long, C.4
Li, D.5
Duan, D.6
-
13
-
-
80053576108
-
AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice
-
online publication on August 2 2011. doi:10.1038/mt.2011.154
-
Bostick B, Shin J-H, Yue Y, Duan D. AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice. Mol Ther 2011, online publication on August 2 2011. doi:10.1038/mt.2011.154.
-
(2011)
Mol Ther
-
-
Bostick, B.1
Shin, J.-.H.2
Yue, Y.3
Duan, D.4
-
14
-
-
77957671887
-
Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy
-
10.1002/mus.21763, 3109082, 20878741
-
Bostick B, Yue Y, Duan D. Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve 2010, 42:600-603. 10.1002/mus.21763, 3109082, 20878741.
-
(2010)
Muscle Nerve
, vol.42
, pp. 600-603
-
-
Bostick, B.1
Yue, Y.2
Duan, D.3
-
15
-
-
37849000464
-
Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression
-
10.1161/CIRCRESAHA.107.162982, 17967782
-
Bostick B, Yue Y, Long C, Duan D. Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression. Circ Res 2008, 102:121-130. 10.1161/CIRCRESAHA.107.162982, 17967782.
-
(2008)
Circ Res
, vol.102
, pp. 121-130
-
-
Bostick, B.1
Yue, Y.2
Long, C.3
Duan, D.4
-
16
-
-
34047115768
-
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins
-
10.1016/j.yjmcc.2007.01.003, 1945057, 17300800
-
Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, Tsuji T, Takewa Y, del Monte F, Peluso R, Zsebo K, Jeong D, Park WJ, Kawase Y, Hajjar RJ. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol 2007, 42:852-861. 10.1016/j.yjmcc.2007.01.003, 1945057, 17300800.
-
(2007)
J Mol Cell Cardiol
, vol.42
, pp. 852-861
-
-
Sakata, S.1
Lebeche, D.2
Sakata, N.3
Sakata, Y.4
Chemaly, E.R.5
Liang, L.F.6
Tsuji, T.7
Takewa, Y.8
del Monte, F.9
Peluso, R.10
Zsebo, K.11
Jeong, D.12
Park, W.J.13
Kawase, Y.14
Hajjar, R.J.15
-
17
-
-
40649106736
-
Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure
-
10.1016/j.jacc.2007.12.014, 18342232
-
Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, Tanguay JF, Hajjar RJ. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 2008, 51:1112-1119. 10.1016/j.jacc.2007.12.014, 18342232.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1112-1119
-
-
Kawase, Y.1
Ly, H.Q.2
Prunier, F.3
Lebeche, D.4
Shi, Y.5
Jin, H.6
Hadri, L.7
Yoneyama, R.8
Hoshino, K.9
Takewa, Y.10
Sakata, S.11
Peluso, R.12
Zsebo, K.13
Gwathmey, J.K.14
Tardif, J.C.15
Tanguay, J.F.16
Hajjar, R.J.17
-
18
-
-
44449114156
-
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
-
10.1016/j.cardfail.2008.02.005, 18514926
-
Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail 2008, 14:355-367. 10.1016/j.cardfail.2008.02.005, 18514926.
-
(2008)
J Card Fail
, vol.14
, pp. 355-367
-
-
Hajjar, R.J.1
Zsebo, K.2
Deckelbaum, L.3
Thompson, C.4
Rudy, J.5
Yaroshinsky, A.6
Ly, H.7
Kawase, Y.8
Wagner, K.9
Borow, K.10
Jaski, B.11
London, B.12
Greenberg, B.13
Pauly, D.F.14
Patten, R.15
Starling, R.16
Mancini, D.17
Jessup, M.18
-
19
-
-
62649133817
-
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial
-
10.1016/j.cardfail.2009.01.013, 2752875, 19327618
-
Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail 2009, 15:171-181. 10.1016/j.cardfail.2009.01.013, 2752875, 19327618.
-
(2009)
J Card Fail
, vol.15
, pp. 171-181
-
-
Jaski, B.E.1
Jessup, M.L.2
Mancini, D.M.3
Cappola, T.P.4
Pauly, D.F.5
Greenberg, B.6
Borow, K.7
Dittrich, H.8
Zsebo, K.M.9
Hajjar, R.J.10
-
20
-
-
33947247444
-
Efficient whole-body transduction with trans-splicing adeno-associated viral vectors
-
2581720, 17264855
-
Ghosh A, Yue Y, Long C, Bostick B, Duan D. Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol Ther 2007, 15:750-755. 2581720, 17264855.
-
(2007)
Mol Ther
, vol.15
, pp. 750-755
-
-
Ghosh, A.1
Yue, Y.2
Long, C.3
Bostick, B.4
Duan, D.5
-
21
-
-
35848961457
-
Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration
-
10.1038/sj.gt.3303029, 17898796
-
Bostick B, Ghosh A, Yue Y, Long C, Duan D. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther 2007, 14:1605-1609. 10.1038/sj.gt.3303029, 17898796.
-
(2007)
Gene Ther
, vol.14
, pp. 1605-1609
-
-
Bostick, B.1
Ghosh, A.2
Yue, Y.3
Long, C.4
Duan, D.5
-
22
-
-
27944479711
-
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
-
10.1038/nbt1153, 2581721, 16244658
-
Lai Y, Yue Y, Liu M, Ghosh A, Engelhardt JF, Chamberlain JS, Duan D. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol 2005, 23:1435-1439. 10.1038/nbt1153, 2581721, 16244658.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1435-1439
-
-
Lai, Y.1
Yue, Y.2
Liu, M.3
Ghosh, A.4
Engelhardt, J.F.5
Chamberlain, J.S.6
Duan, D.7
-
23
-
-
4544225876
-
Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency
-
2431462, 15353044
-
Xu Z, Yue Y, Lai Y, Ye C, Qiu J, Pintel DJ, Duan D. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum Gene Ther 2004, 15:896-905. 2431462, 15353044.
-
(2004)
Hum Gene Ther
, vol.15
, pp. 896-905
-
-
Xu, Z.1
Yue, Y.2
Lai, Y.3
Ye, C.4
Qiu, J.5
Pintel, D.J.6
Duan, D.7
-
24
-
-
0032693757
-
Submucosal Gland Development in the Airway is Controlled by Lymphoid Enhancer Binding Factor-1 (Lef-1)
-
Duan D, Yue Y, Zhou W, Labed B, Ritche TC, Grosschedl R, Engelhardt JF. Submucosal Gland Development in the Airway is Controlled by Lymphoid Enhancer Binding Factor-1 (Lef-1). Development 1999, 126:4441-4453.
-
(1999)
Development
, vol.126
, pp. 4441-4453
-
-
Duan, D.1
Yue, Y.2
Zhou, W.3
Labed, B.4
Ritche, T.C.5
Grosschedl, R.6
Engelhardt, J.F.7
-
25
-
-
63649114966
-
Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice
-
10.1038/mt.2008.264, 2714701,2714701, 19066599
-
Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther 2009, 17:253-261. 10.1038/mt.2008.264, 2714701,2714701, 19066599.
-
(2009)
Mol Ther
, vol.17
, pp. 253-261
-
-
Bostick, B.1
Yue, Y.2
Long, C.3
Marschalk, N.4
Fine, D.M.5
Chen, J.6
Duan, D.7
-
26
-
-
77954244874
-
SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells
-
10.1038/mt.2010.77, 2911258, 20461063
-
Hadri L, Bobe R, Kawase Y, Ladage D, Ishikawa K, Atassi F, Lebeche D, Kranias EG, Leopold JA, Lompre AM, Lompré AM, Lipskaia L, Hajjar RJ. SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells. Mol Ther 2010, 18:1284-1292. 10.1038/mt.2010.77, 2911258, 20461063.
-
(2010)
Mol Ther
, vol.18
, pp. 1284-1292
-
-
Hadri, L.1
Bobe, R.2
Kawase, Y.3
Ladage, D.4
Ishikawa, K.5
Atassi, F.6
Lebeche, D.7
Kranias, E.G.8
Leopold, J.A.9
Lompre, A.M.10
Lompré, A.M.11
Lipskaia, L.12
Hajjar, R.J.13
-
27
-
-
33745248418
-
C-terminal truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double knock-out mice
-
10.1016/j.ymthe.2006.01.007, 2581714, 16563874
-
Yue Y, Liu M, Duan D. C-terminal truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double knock-out mice. Mol Ther 2006, 14:79-87. 10.1016/j.ymthe.2006.01.007, 2581714, 16563874.
-
(2006)
Mol Ther
, vol.14
, pp. 79-87
-
-
Yue, Y.1
Liu, M.2
Duan, D.3
-
28
-
-
79960072612
-
Phenotyping cardiac gene therapy in mice
-
10.1007/978-1-61737-982-6_6, 3118042, 21194023
-
Bostick B, Yue Y, Duan D. Phenotyping cardiac gene therapy in mice. Methods Mol Biol 2011, 709:91-104. 10.1007/978-1-61737-982-6_6, 3118042, 21194023.
-
(2011)
Methods Mol Biol
, vol.709
, pp. 91-104
-
-
Bostick, B.1
Yue, Y.2
Duan, D.3
-
29
-
-
33749004495
-
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy
-
2581718, 16987891
-
Duan D. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum Mol Genet 2006, 15(Spec No 2):R253-261. 2581718, 16987891.
-
(2006)
Hum Mol Genet
, vol.15
, Issue.SPEC NO 2
-
-
Duan, D.1
-
30
-
-
77957914859
-
Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation
-
10.1161/CIRCHEARTFAILURE.109.891184, 20634484
-
Beeri R, Chaput M, Guerrero JL, Kawase Y, Yosefy C, Abedat S, Karakikes I, Morel C, Tisosky A, Sullivan S, Handschumacher MD, Gilon D, Vlahakes GJ, Hajjar RJ, Levine RA. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circ Heart Fail 2010, 3:627-634. 10.1161/CIRCHEARTFAILURE.109.891184, 20634484.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 627-634
-
-
Beeri, R.1
Chaput, M.2
Guerrero, J.L.3
Kawase, Y.4
Yosefy, C.5
Abedat, S.6
Karakikes, I.7
Morel, C.8
Tisosky, A.9
Sullivan, S.10
Handschumacher, M.D.11
Gilon, D.12
Vlahakes, G.J.13
Hajjar, R.J.14
Levine, R.A.15
-
31
-
-
79961032369
-
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure
-
10.1161/CIRCULATIONAHA.111.022889, 21709064
-
Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure. Circulation 2011, 124:304-313. 10.1161/CIRCULATIONAHA.111.022889, 21709064.
-
(2011)
Circulation
, vol.124
, pp. 304-313
-
-
Jessup, M.1
Greenberg, B.2
Mancini, D.3
Cappola, T.4
Pauly, D.F.5
Jaski, B.6
Yaroshinsky, A.7
Zsebo, K.M.8
Dittrich, H.9
Hajjar, R.J.10
-
32
-
-
21244467179
-
Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice
-
10.1111/j.1365-201X.2005.01450.x, 15954985
-
Divet A, Lompre AM, Huchet-Cadiou C. Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice. Acta Physiol Scand 2005, 184:173-186. 10.1111/j.1365-201X.2005.01450.x, 15954985.
-
(2005)
Acta Physiol Scand
, vol.184
, pp. 173-186
-
-
Divet, A.1
Lompre, A.M.2
Huchet-Cadiou, C.3
-
33
-
-
65449122304
-
Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy
-
10.1111/j.1745-7599.2009.00404.x, 19432907
-
Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract 2009, 21:241-249. 10.1111/j.1745-7599.2009.00404.x, 19432907.
-
(2009)
J Am Acad Nurse Pract
, vol.21
, pp. 241-249
-
-
Kaspar, R.W.1
Allen, H.D.2
Montanaro, F.3
-
34
-
-
0141841602
-
Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart
-
10.1161/01.CIR.0000089371.11664.27, 2581719, 12952841
-
Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D. Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart. Circulation 2003, 108:1626-1632. 10.1161/01.CIR.0000089371.11664.27, 2581719, 12952841.
-
(2003)
Circulation
, vol.108
, pp. 1626-1632
-
-
Yue, Y.1
Li, Z.2
Harper, S.Q.3
Davisson, R.L.4
Chamberlain, J.S.5
Duan, D.6
-
35
-
-
34249337407
-
Systemic Administration of Micro-dystrophin Restores Cardiac Geometry and Prevents Dobutamine-induced Cardiac Pump Failure
-
Townsend D, Blankinship MJ, Allen JM, Gregorevic P, Chamberlain JS, Metzger JM. Systemic Administration of Micro-dystrophin Restores Cardiac Geometry and Prevents Dobutamine-induced Cardiac Pump Failure. Mol Ther 2007, 15:1086-1092.
-
(2007)
Mol Ther
, vol.15
, pp. 1086-1092
-
-
Townsend, D.1
Blankinship, M.J.2
Allen, J.M.3
Gregorevic, P.4
Chamberlain, J.S.5
Metzger, J.M.6
-
36
-
-
54449095504
-
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
-
10.1073/pnas.0805676105, 2546441, 18806224
-
Wu B, Moulton HM, Iversen PL, Jiang J, Li J, Spurney CF, Sali A, Guerron AD, Nagaraju K, Doran T, Lu P, Xiao X, Lu QL. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc Natl Acad Sci USA 2008, 105:14814-14819. 10.1073/pnas.0805676105, 2546441, 18806224.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 14814-14819
-
-
Wu, B.1
Moulton, H.M.2
Iversen, P.L.3
Jiang, J.4
Li, J.5
Spurney, C.F.6
Sali, A.7
Guerron, A.D.8
Nagaraju, K.9
Doran, T.10
Lu, P.11
Xiao, X.12
Lu, Q.L.13
-
37
-
-
77957725001
-
Dystrophin immunity in Duchenne's muscular dystrophy
-
10.1056/NEJMoa1000228, 3014106, 20925545
-
Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark KR, Li J, Xiao X, Samulski J, McPhee SW, Samulski RJ, Walker CM. Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med 2010, 363:1429-1437. 10.1056/NEJMoa1000228, 3014106, 20925545.
-
(2010)
N Engl J Med
, vol.363
, pp. 1429-1437
-
-
Mendell, J.R.1
Campbell, K.2
Rodino-Klapac, L.3
Sahenk, Z.4
Shilling, C.5
Lewis, S.6
Bowles, D.7
Gray, S.8
Li, C.9
Galloway, G.10
Malik, V.11
Coley, B.12
Clark, K.R.13
Li, J.14
Xiao, X.15
Samulski, J.16
McPhee, S.W.17
Samulski, R.J.18
Walker, C.M.19
-
38
-
-
33748313277
-
New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD
-
10.1007/s10974-006-9085-2, 16897576
-
Constantin B, Sebille S, Cognard C. New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. J Muscle Res Cell Motil 2006, 27:375-386. 10.1007/s10974-006-9085-2, 16897576.
-
(2006)
J Muscle Res Cell Motil
, vol.27
, pp. 375-386
-
-
Constantin, B.1
Sebille, S.2
Cognard, C.3
-
39
-
-
77649139843
-
Calcium and the damage pathways in muscular dystrophy
-
10.1139/Y09-058, 21128333
-
Allen DG, Gervasio OL, Yeung EW, Whitehead NP. Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 2010, 88:83-91. 10.1139/Y09-058, 21128333.
-
(2010)
Can J Physiol Pharmacol
, vol.88
, pp. 83-91
-
-
Allen, D.G.1
Gervasio, O.L.2
Yeung, E.W.3
Whitehead, N.P.4
-
40
-
-
23944459786
-
Dystrophic heart failure blocked by membrane sealant poloxamer
-
10.1038/nature03844, 16025101
-
Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, Metzger JM. Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 2005, 436:1025-1029. 10.1038/nature03844, 16025101.
-
(2005)
Nature
, vol.436
, pp. 1025-1029
-
-
Yasuda, S.1
Townsend, D.2
Michele, D.E.3
Favre, E.G.4
Day, S.M.5
Metzger, J.M.6
-
41
-
-
68149169018
-
Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes
-
10.1016/j.ceca.2009.06.002, 2745084, 19604578
-
Fanchaouy M, Polakova E, Jung C, Ogrodnik J, Shirokova N, Niggli E. Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium 2009, 46:114-121. 10.1016/j.ceca.2009.06.002, 2745084, 19604578.
-
(2009)
Cell Calcium
, vol.46
, pp. 114-121
-
-
Fanchaouy, M.1
Polakova, E.2
Jung, C.3
Ogrodnik, J.4
Shirokova, N.5
Niggli, E.6
-
42
-
-
27844451982
-
Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice
-
10.1152/ajpheart.00448.2005, 16024571
-
Janssen PM, Hiranandani N, Mays TA, Rafael-Fortney JA. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 2005, 289:H2373-2378. 10.1152/ajpheart.00448.2005, 16024571.
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
-
-
Janssen, P.M.1
Hiranandani, N.2
Mays, T.A.3
Rafael-Fortney, J.A.4
-
43
-
-
79952209778
-
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle
-
10.1172/JCI43844, 3049367, 21285509
-
Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, Molkentin JD. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest 2011, 121:1044-1052. 10.1172/JCI43844, 3049367, 21285509.
-
(2011)
J Clin Invest
, vol.121
, pp. 1044-1052
-
-
Goonasekera, S.A.1
Lam, C.K.2
Millay, D.P.3
Sargent, M.A.4
Hajjar, R.J.5
Kranias, E.G.6
Molkentin, J.D.7
|